# Takeda Pharmaceutical Co Ltd: Form 4, filed Jun 9, 2021

- Company: [Takeda Pharmaceutical Co Ltd](/companies/tak.md) (CIK 1395064)
- Form: 4
- Filed: 2021-06-09
- Accepted by EDGAR: Jun 9, 2021, 06:41 ET
- Period: 2021-06-07
- Accession: 0001395064-21-000109
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1395064/000139506421000109/xslF345X03/wf-form4_162323525319328.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395064/000139506421000109/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395064/000139506421000109/xslF345X03/wf-form4_162323525319328.xml

Filed Jun 9, 2021.
Source: SEC EDGAR, the filing index for accession 0001395064-21-000109. Last ingested by Listed: Nov 5, 2026, 16:17 ET. No prices; not investment advice.